Zynerba Cannabis Drug Fails Fragile X Test

Green Market Report
By Debra BorchardtJun 30, 2020, 8:52 am264 pts
Some drugs work and at other times they don’t, which is the whole point of testing and the importance of trying to find solutions to patient conditions. Unfortunately for Zynerba Pharmaceuticals, Inc. (ZYNE) its latest top-line results from the 14-week pivotal CONNECT-FX (Clinical study of Cannabidiol (CBD)…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Canadian Cannabis Sales Drop Again 70

Delaware Senators Approve House-Passed Marijuana Banking Bill To Provide State-Level Protections 69

Aelius LED Nominated for Best Lighting System Award at Grow-Up Awards for 3rd Consecutive Year 62

Congress could include marijuana banking in FAA, crypto bills 57

Minnesota lawmakers urged to approve adult-use marijuana cultivation 56

Manitoba NDP table bill to repeal ban on home-grown cannabis 56

Manitoba to pause issuing controlled access retail cannabis licences 54

Manitoba expected to overturn ban on homegrown cannabis 53

About NewsBudz

NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.

Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.